October 19, 2020
No Pfizer COVID-19 Vaccine Expected Before Election
MONDAY, Oct. 19, 2020 (HealthDay News) — Pfizer will not apply for emergency authorization of its COVID-19 vaccine before the third week in November, the company’s chief executive said in a statement posted to the Pfizer website on Friday. This is a reversal from the company’s previous claims that it would apply for the approval...
Pandemic Taking Toll on the Mental Health of Health Care Staff
MONDAY, Oct. 19, 2020 (HealthDay News) — Mental health disorders are common in health care workers (HCWs) during and immediately following a pandemic, according to a review published online Oct. 15 in the European Journal of Psychotraumatology. Sophie M. Allan, from the University of East Anglia in the United Kingdom, and colleagues estimated the prevalence...
Emergency Sick Leave Helped to Flatten the U.S. COVID-19 Curve
MONDAY, Oct. 19, 2020 (HealthDay News) — The U.S. emergency sick leave provision in the Families First Coronavirus Response Act (FFCRA) was a highly effective policy tool to flatten the curve in the short run, according to a report published online Oct. 15 in Health Affairs. Stefan Pichler, Ph.D., from the KOF Swiss Economic Institute...
Neurologic Complications Seen in Hospitalized COVID-19 Patients
MONDAY, Oct. 19, 2020 (HealthDay News) — Neurologic disorders are not uncommon in hospitalized COVID-19 patients, according to a study published online Oct. 5 in Neurology. Jennifer A. Frontera, M.D., from the New York University Grossman School of Medicine in New York City, and colleagues prospectively followed hospitalized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive...
Risk for Severe COVID-19 Low With Congenital Heart Disease
MONDAY, Oct. 19, 2020 (HealthDay News) — Most patients with congenital heart disease (CHD) are not at risk for severe COVID-19 infection, according to a study published online Oct. 14 in the Journal of the American Heart Association. Matthew J. Lewis, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues...
Inactivated SARS-CoV-2 Vaccine Well Tolerated in Phase 1/2 Trial
MONDAY, Oct. 19, 2020 (HealthDay News) — An inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine seems safe and induces humoral responses, according to a study published online Oct. 15 in The Lancet Infectious Diseases. Shengli Xia, from the Henan Provincial Center for Disease Control and Prevention in China, and colleagues conducted a phase...
COVID-19-Linked Deaths Mainly in Seniors in May to August 2020
MONDAY, Oct. 19, 2020 (HealthDay News) — From May to August 2020, COVID-19-associated deaths occurred mainly among older adults and in certain racial and ethnic minorities, especially Hispanics, according to research published in the Oct. 16 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Jeremy A.W. Gold,...